A detailed history of Wolverine Asset Management LLC transactions in Alvotech stock. As of the latest transaction made, Wolverine Asset Management LLC holds 5,841 shares of ALVO stock, worth $69,566. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,841
Holding current value
$69,566
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$10.76 - $12.99 $62,849 - $75,874
5,841 New
5,841 $69,000
Q4 2023

Feb 01, 2024

SELL
$8.55 - $11.48 $99,436 - $133,512
-11,630 Reduced 65.13%
6,227 $71,000
Q3 2023

Nov 13, 2023

BUY
$8.12 - $10.07 $714 - $886
88 Added 0.5%
17,857 $162,000
Q2 2023

Aug 07, 2023

BUY
$6.9 - $13.85 $106,211 - $213,193
15,393 Added 647.85%
17,769 $137,000
Q1 2023

May 08, 2023

BUY
$10.01 - $14.03 $23,783 - $33,335
2,376 New
2,376 $30,000

Others Institutions Holding ALVO

About Alvotech


  • Ticker ALVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 248,650,000
  • Market Cap $2.96B
  • Description
  • Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...
More about ALVO
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.